about
Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a modelThe tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentinA Decade of Molecular Understanding of Withanolide Biosynthesis and In vitro Studies in Withania somnifera (L.) Dunal: Prospects and Perspectives for Pathway EngineeringKinases as druggable targets in trypanosomatid protozoan parasitesEvasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.Broad targeting of angiogenesis for cancer prevention and therapyWithaferin A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-κB signalingWithania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transitionA novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stressHuman iPSC-derived endothelial cell sprouting assay in synthetic hydrogel arraysVimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studiesWithaferin a alters intermediate filament organization, cell shape and behaviorWithaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivoWater extract of Ashwagandha leaves has anticancer activity: identification of an active component and its mechanism of actionSynthesis and mechanistic studies of a novel homoisoflavanone inhibitor of endothelial cell growthWithaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cellsNovel Methods to Generate Active Ingredients-Enriched Ashwagandha Leaves and ExtractsA small molecule inhibitor of NFκB blocks ER stress and the NLRP3 inflammasome and prevents progression of pancreatitis.Real-time analysis of epithelial-mesenchymal transition using fluorescent single-domain antibodiesWithaferin A Analogs That Target the AAA+ Chaperone p97.Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa.Switch in FOXA1 status associates with endometrial cancer progressionWithaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.Withania somnifera targets interleukin-8 and cyclooxygenase-2 in human prostate cancer progression.Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosisA Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer CellsProbing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes.Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species.Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cellsWithaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells.Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancerWithaferin A induces proteasome inhibition, endoplasmic reticulum stress, the heat shock response and acquisition of thermotolerance.Targeting Notch Signaling in Colorectal Cancer.Tumor necrosis factor-α sensitizes breast cancer cells to natural products with proteasome-inhibitory activity leading to apoptosisWithaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity.Withaferin A effectively targets soluble vimentin in the glaucoma filtration surgical model of fibrosis.Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.Role of the cytoskeleton in formation and maintenance of angiogenic sproutsAyurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells
P2860
Q21143797-1D796740-C6A4-46E0-9547-76D1E3264FDCQ24633116-DF535730-E4C2-456B-97E5-C8FC05E1BB2DQ26774118-2F15AEA5-7893-4000-B482-93B9B104FD1BQ26786761-B27B9095-8B70-4B9B-9CA8-4BF15D373EFEQ26827810-BCDC9DF3-AFD5-489F-B0FD-451FAB3AE858Q27002903-D87AD5FD-8A92-44CC-AFEE-8EAD43BE23D8Q27302812-C0F07124-859D-45CC-8EEE-18A17EF6AF23Q27305726-07739EA4-2F94-4480-A222-2FF37F80DC9BQ27321296-B1F8A1AD-07ED-41B6-9D84-546590B688DAQ28394074-C12AE841-31AA-41FF-982F-9ADD0F42B8F1Q28397986-BBF85BC5-6A39-4532-AF8C-CED5A1D85F4FQ28473693-E382AA65-4351-445E-9EDD-33C2469B3096Q28480441-62A0C89E-9A1D-4489-B9B5-68F54F3BA932Q28482366-CB6A17BD-F4FD-4F75-9454-D81F66435711Q28534335-6FEFBC79-6A40-4ECC-B7D7-CF880B0FA4A2Q28538093-2C4079F6-29F6-4F61-AD11-AD68D487B542Q28543359-C4EAA4CD-2C53-47BF-89DC-8420C1196EE8Q28554871-8F047CE1-45B1-49B8-923D-538C25FB4B0CQ30276361-6946493A-9BA9-4B65-B034-5063F3C0391BQ30661925-99177BD6-9D79-4334-A1CD-6D360BC05238Q33360763-0A39FCCE-42E1-48D3-80D6-8A76774646C3Q33450973-7D36CCB9-9ADA-45C7-A63C-90C7715438DDQ33645463-D8B2D870-BDA2-4C00-9A82-8869AAF820B5Q33690570-B442777A-B911-43DF-A263-D1E558E733D6Q33739134-6B335AB7-BF54-4ADB-9346-2D75D27F727CQ33748201-F91EB731-839F-47CB-9FD4-E965FF186DC1Q33755446-FDCFF065-34B5-4A58-9DBF-3BFE340C35E8Q33766685-FAC62660-6D71-4D32-A3A4-735E03509684Q33997100-D8C50DE0-F852-4680-99D3-D1E8D78419C2Q34042070-32FCFD3F-A5E8-435D-9500-2A0DFE209E39Q34253370-BD9F4315-3706-4A19-AE00-1A4FB5C21D02Q34292101-05447677-04E3-438F-8ACA-76BE6E7E879DQ34316709-4C4E2212-E822-4C94-B620-C314E8D7B703Q34482399-784DD192-9260-459F-B45D-CF21ECF568BFQ34566295-516E0C0A-C3DC-4DB6-B892-B3E88B4F32E0Q34588342-B17C758C-C0B4-4B5C-BA4F-94D4C65CC942Q34718470-077BB13A-D546-420D-9D01-77760C533371Q34828174-DF65F182-0C05-4340-A122-38B4CC806AB6Q34829230-6508B7D6-D1A9-4342-AE18-92B3DD41F619Q34878214-6B2BE31D-E039-4DC2-8635-E582BA57E8F6
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Withaferin A is a potent inhibitor of angiogenesis.
@ast
Withaferin A is a potent inhibitor of angiogenesis.
@en
Withaferin A is a potent inhibitor of angiogenesis.
@nl
type
label
Withaferin A is a potent inhibitor of angiogenesis.
@ast
Withaferin A is a potent inhibitor of angiogenesis.
@en
Withaferin A is a potent inhibitor of angiogenesis.
@nl
prefLabel
Withaferin A is a potent inhibitor of angiogenesis.
@ast
Withaferin A is a potent inhibitor of angiogenesis.
@en
Withaferin A is a potent inhibitor of angiogenesis.
@nl
P2093
P1433
P1476
Withaferin A is a potent inhibitor of angiogenesis.
@en
P2093
Antonio Ruiz
Art D Hanson
Barry P Conner
Christopher J Herbstritt
Hans J Hammers
John Rougas
Paola Bargagna-Mohan
Royce Mohan
Victor S Pribluda
P2888
P304
P356
10.1007/S10456-004-1026-3
P577
2004-01-01T00:00:00Z